VOLUME 6 (2015)
Table of Contents
Editorial
|
| Doxycycline: new tricks for an old drug |
|
https://doi.org/10.18632/oncotarget.5111
|
| 19336-19337 |
|
| Targeting vascular leakage in lung inflammation |
|
https://doi.org/10.18632/oncotarget.4907
|
| 19338-19339 |
|
| Sonic Hedgehog: a lipid speciated hormone |
|
https://doi.org/10.18632/oncotarget.4969
|
| 19340-19341 |
|
| Posttranslesion synthesis repair |
|
https://doi.org/10.18632/oncotarget.4938
|
| 19342-19343 |
|
| Tolerogenic citrullinated peptide for arthritis |
|
https://doi.org/10.18632/oncotarget.5016
|
| 19344-19345 |
|
| Cytokine treatment in cancer immunotherapy |
|
https://doi.org/10.18632/oncotarget.5095
|
| 19346-19347 |
|
| MAPK phosphatase 5 inhibits IRF3 |
|
https://doi.org/10.18632/oncotarget.5096
|
| 19348-19349 |
|
| Fibronectin orchestrates thrombosis and hemostasis |
|
https://doi.org/10.18632/oncotarget.5097
|
| 19350-19351 |
|
| Sortilin and atherosclerosis |
|
https://doi.org/10.18632/oncotarget.5098
|
| 19352-19353 |
|
| FBH1: a new checkpoint factor |
|
https://doi.org/10.18632/oncotarget.5099
|
| 19354-19355 |
|
| Cracking the tubulin code of mitosis |
|
https://doi.org/10.18632/oncotarget.5108
|
| 19356-19357 |
Editorial: Chromosome
|
| Repair by a molecular DNA ambulance |
|
https://doi.org/10.18632/oncotarget.5140
|
| 19358-19359 |
|
| Chromosome gains drive childhood ALL |
|
https://doi.org/10.18632/oncotarget.5141
|
| 19360-19361 |
Editorial: Immunology
|
| SRSF1 inhibition of HIV1 gene expression |
|
https://doi.org/10.18632/oncotarget.5125
|
| 19362-19363 |
|
| Impact of influenza PAX on host response |
|
https://doi.org/10.18632/oncotarget.5127
|
| 19364-19365 |
Reviews
|
| Radioresistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic |
|
https://doi.org/10.18632/oncotarget.4358
|
| 19366-19380 |
|
| The MYC/miR1792 axis in lymphoproliferative disorders: A common pathway with therapeutic potential |
|
https://doi.org/10.18632/oncotarget.4574
|
| 19381-19392 |
|
| The anticancer immune response of antiPD1/PDL1 and the genetic determinants of response to antiPD1/PDL1 antibodies in cancer patients |
|
https://doi.org/10.18632/oncotarget.5107
|
| 19393-19404 |
Research Perspectives
|
| Rejuvenating immunity: “antiaging drug today†eight years later |
|
https://doi.org/10.18632/oncotarget.3740
|
| 19405-19412 |
Priority Research Papers
|
| Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem celllike properties and sensitivity to HDAC inhibition |
|
https://doi.org/10.18632/oncotarget.4989
|
| 19413-19427 |
Research Papers: Gerotarget (Focus on Aging)
|
| Influence of nonsteroidal antiinflammatory drugs on Drosophila melanogaster longevity |
|
https://doi.org/10.18632/oncotarget.5118
|
| 19428-19444 |
|
| BTLA expression declines on B cells of the aged and is associated with low responsiveness to the trivalent influenza vaccine |
|
https://doi.org/10.18632/oncotarget.4597
|
| 19445-19455 |
Research Papers
|
| Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3318
|
| 19456-19468 |
|
| Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumorderived VEGF in tumor model through modulating VEGFVEGFR2 signaling pathway |
|
https://doi.org/10.18632/oncotarget.3625
|
| 19469-19482 |
|
| Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific |
|
https://doi.org/10.18632/oncotarget.4287
|
| 19483-19499 |
|
| Epithelial to mesenchymal transition is associated with rapamycin resistance |
|
https://doi.org/10.18632/oncotarget.3669
|
| 19500-19513 |
|
| Citrus limonderived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAILmediated cell death |
|
https://doi.org/10.18632/oncotarget.4004
|
| 19514-19527 |
|
| OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer |
|
https://doi.org/10.18632/oncotarget.3683
|
| 19528-19541 |
|
| The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer |
|
https://doi.org/10.18632/oncotarget.4295
|
| 19542-19551 |
|
| ING5 suppresses proliferation apoptosis migration and invasion and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression |
|
https://doi.org/10.18632/oncotarget.3735
|
| 19552-19579 |
|
| Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3973
|
| 19580-19591 |
|
| Extracellular galectin3 programs multidrug resistance through Na+/K+ATPase and Pglycoprotein signaling |
|
https://doi.org/10.18632/oncotarget.4285
|
| 19592-19604 |
|
| ERK5 negatively regulates tobacco smokeinduced pulmonary epithelial–mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3747
|
| 19605-19618 |
|
| In1ghrelin a splice variant of ghrelin gene is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical cellular and molecular parameters |
|
https://doi.org/10.18632/oncotarget.4316
|
| 19619-19633 |
|
| CD44 enhances tumor aggressiveness by promoting tumor cell plasticity |
|
https://doi.org/10.18632/oncotarget.3839
|
| 19634-19646 |
|
| FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells |
|
https://doi.org/10.18632/oncotarget.3794
|
| 19647-19660 |
|
| CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations |
|
https://doi.org/10.18632/oncotarget.3875
|
| 19661-19670 |
|
| The MUTYH base excision repair gene protects against inflammationassociated colorectal carcinogenesis |
|
https://doi.org/10.18632/oncotarget.4284
|
| 19671-19684 |
|
| BTG1 expression correlates with pathogenesis aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy |
|
https://doi.org/10.18632/oncotarget.4081
|
| 19685-19705 |
|
| Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism |
|
https://doi.org/10.18632/oncotarget.3565
|
| 19706-19720 |
|
| COP1 enhances ubiquitinmediated degradation of p27Kip1 to promote cancer cell growth |
|
https://doi.org/10.18632/oncotarget.3821
|
| 19721-19734 |
|
| Inhibition of colorectal cancer stem cell survival and invasive potential by hsamiR1405p mediated suppression of Smad2 and autophagy |
|
https://doi.org/10.18632/oncotarget.3771
|
| 19735-19746 |
|
| Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model |
|
https://doi.org/10.18632/oncotarget.3850
|
| 19747-19758 |
|
| The long noncoding RNA TUG1 regulates bloodtumor barrier permeability by targeting miR144 |
|
https://doi.org/10.18632/oncotarget.4331
|
| 19759-19779 |
|
| Expression alterations define unique molecular characteristics of spinal ependymomas |
|
https://doi.org/10.18632/oncotarget.3715
|
| 19780-19791 |
|
| Heme oxygenase1 promotes tumor progression and metastasis of colorectal carcinoma cells by inhibiting antitumor immunity |
|
https://doi.org/10.18632/oncotarget.4075
|
| 19792-19806 |
|
| miR181b as a therapeutic agent for chronic lymphocytic leukemia in the EµTCL1 mouse model |
|
https://doi.org/10.18632/oncotarget.4415
|
| 19807-19818 |
|
| Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PDL1 |
|
https://doi.org/10.18632/oncotarget.4378
|
| 19819-19825 |
|
| RTVP1 regulates glioma cell migration and invasion via interaction with NWASP and hnRNPK |
|
https://doi.org/10.18632/oncotarget.4471
|
| 19826-19840 |
|
| The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy |
|
https://doi.org/10.18632/oncotarget.3734
|
| 19841-19867 |
Clinical Research Papers
|
| Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF NRAS and EGFR evaluation |
|
https://doi.org/10.18632/oncotarget.4503
|
| 19868-19879 |
|
| Metabolic syndrome contributes to an increased recurrence risk of nonmetastatic colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4166
|
| 19880-19890 |
|
| Somatic copy number alterations detected by ultradeep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.4336
|
| 19891-19906 |
|
| Serum dickkopf1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.4529
|
| 19907-19917 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
